Neuraxis (NRXS) Assets (2022 - 2025)
Neuraxis (NRXS) posted Assets of $6.4 million for Q4 2025, up 10.87% sequentially from $5.8 million in Q3 2025, and up 34.61% YoY from $4.8 million in Q4 2024.
Neuraxis (NRXS) Assets (2022 - 2025) Analysis & Trends
Neuraxis has reported Assets for 4 years, with the latest figure at $6.4 million in Q4 2025.
- Quarterly Assets rose 34.61% year-over-year to $6.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.4 million (up 34.61% YoY) and the FY2025 annual result came in at $6.4 million, up 34.61% from the prior year.
- Assets rose to $6.4 million in Q4 2025 per NRXS's latest filing, from $5.8 million in the prior quarter.
- Over five years, Assets peaked at $7.1 million in Q2 2025 and troughed at $509498.0 in Q4 2023.
- A 4-year average of $3.0 million and a median of $2.1 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2024: Assets sank 65.59% in 2023, then soared 833.78% in 2024.
- Over 4 years, Assets stood at $1.5 million in 2022, then tumbled by 65.59% to $509498.0 in 2023, then jumped by 833.78% to $4.8 million in 2024, then soared by 34.61% to $6.4 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $6.4 million, $5.8 million, and $7.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Neuraxis | 74.54 Mn | 66.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.40 Mn |
| Sep 30, 2025 | 5.78 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | 4.76 Mn |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 945,729.00 |
| Dec 31, 2023 | 509,498.00 |
| Sep 30, 2023 | 1.24 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Dec 31, 2022 | 1.48 Mn |